Overview
Details
Chat
Baxter International Inc. (BAX.US) Q1 2022 Earnings Conference Call
Live streaming time: 28/04/2022 15:55
Baxter International is committed to providing a basic portfolio of renal and hospital products, including acute and chronic dialysis, sterile intravenous infusion, infusion systems and equipment, parenteral nutrition therapy, premixed and oncolytic injections, biologics and surgical products and anesthesia drugs, drug recombination system and pharmacy automation, software and services. It operates through the following market segments: Americas, Europe, Middle East and Africa (EMEA), Asia Pacific (APAC) and Hillrom. The Americas, EMEA and APAC market segments offer a basic healthcare product portfolio. The Hillrom segment provides digital and interconnected care solutions and collaborative tools, including smart bed systems, patient monitoring and diagnostic technology, respiratory health equipment and advanced equipment for surgical fields. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, Illinois.
Risk and Disclaimer Statement:
The content on this page reflects the personal opinion of the author and is intended solely as general information for your reference. It shall not be construed as advice or a basis for any specific investment, business, or commercial decisions. The views expressed in the content do not represent any position of Longbridge or any investment recommendations or endorsements related to LongPort. Longbridge does not make any guarantee or commitment to the truthfulness, accuracy, or originality of the content. Investors should analyze the risks related to the investment based on their own circumstances and seek advice from a professional investment advisor when necessary.
© 2026 Longbridge|Disclaimer
